Cite

HARVARD Citation

    Buja, A. et al. (2021). Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model. Thoracic cancer. 12 (1), pp. 13-20. [Online]. 
  
Back to record